A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines

Completed · Not applicable

Conditions studied: Schizophrenia

In brief

Schizophrenia, a chronic psychiatric disorder, is the second most frequent VA discharge diagnosis. Medication management practices for schizophrenia often are not guideline-concordant and place patients at risk for adverse outcomes. This project tests a new strategy to standard implementation for VHA Schizophrenia Guidelines.

Key facts

Study ID

NCT00013000

Run by

US Department of Veterans Affairs

People needed

400

Expected to finish

2000-09-01

Last updated by the study team

2015-04-07

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must have a diagnosis of schizophrenia. 2. Subjects must have been admitted to an inpatient psychiatry unit or seen in an ambulatory care clinic or the Emergency Room at a study site for symptoms of acute exacerbation. 3. Must be able to provide informed consent themselves or informed consent by a guardian.

Where it is running

• Washington DC VA Medical Center, Washington, DC — Washington D.C., District of Columbia, United States
• Southeast Louisiana Veterans Health Care System, New Orleans, LA — New Orleans, Louisiana, United States
• Tuscaloosa VA Medical Center, Tuscaloosa, AL — Tuscaloosa, Maryland, United States
• VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX — Dallas, Texas, United States
• Michael E. DeBakey VA Medical Center, Houston, TX — Houston, Texas, United States
• South Texas Health Care System, San Antonio, TX — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.